drug

CTX-009

1 story · latest Jul 28, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Compass Therapeutics

Timeline

Compass Therapeutics posts Phase 2 results for CTX-009 in metastatic colorectal cancer trial

Jul 28Trial updateCompass Therapeutics CTX-009

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.